Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle Horspool

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
BMJ Open|June 19, 2025
Promoting smoking cessation and preventing relapse to tobacco use following a smoke-free mental health inpatient stay (SCEPTRE feasibility study): a multicentre randomised controlled feasibility study protocolPetal Petersen Williams, Lisa Huddlestone, Emily Shoesmith, et al.
Pilot and Feasibility Studies|February 17, 2024
Supporting physical activity through co-production in people with severe mental ill health (SPACES): protocol for a randomised controlled feasibility trialGareth Jones, Laura Bailey, Rebecca J Beeken, et al.
Health Technology Assessment (Winchester, England)|October 19, 2022
Optimal pharmacotherapy pathway in adults with diabetic peripheral neuropathic pain: the OPTION-DM RCTSolomon Tesfaye, Gordon Sloan, Jennifer Petrie, et al.
Lancet (London, England)|August 25, 2022
Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trialSolomon Tesfaye, Gordon Sloan, Jennifer Petrie, et al.
Health Technology Assessment (Winchester, England)|September 25, 2019
A bespoke smoking cessation service compared with treatment as usual for people with severe mental ill health: the SCIMITAR+ RCTEmily Peckham, Catherine Arundel, Della Bailey, et al.
The Lancet. Psychiatry|April 13, 2019
Smoking cessation for people with severe mental illness (SCIMITAR+): a pragmatic randomised controlled trialSimon Gilbody, Emily Peckham, Della Bailey, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
BMJ Open|June 19, 2025
Promoting smoking cessation and preventing relapse to tobacco use following a smoke-free mental health inpatient stay (SCEPTRE feasibility study): a multicentre randomised controlled feasibility study protocolPetal Petersen Williams, Lisa Huddlestone, Emily Shoesmith, et al.
Pilot and Feasibility Studies|February 17, 2024
Supporting physical activity through co-production in people with severe mental ill health (SPACES): protocol for a randomised controlled feasibility trialGareth Jones, Laura Bailey, Rebecca J Beeken, et al.
Health Technology Assessment (Winchester, England)|October 19, 2022
Optimal pharmacotherapy pathway in adults with diabetic peripheral neuropathic pain: the OPTION-DM RCTSolomon Tesfaye, Gordon Sloan, Jennifer Petrie, et al.
Lancet (London, England)|August 25, 2022
Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trialSolomon Tesfaye, Gordon Sloan, Jennifer Petrie, et al.
Health Technology Assessment (Winchester, England)|September 25, 2019
A bespoke smoking cessation service compared with treatment as usual for people with severe mental ill health: the SCIMITAR+ RCTEmily Peckham, Catherine Arundel, Della Bailey, et al.
The Lancet. Psychiatry|April 13, 2019
Smoking cessation for people with severe mental illness (SCIMITAR+): a pragmatic randomised controlled trialSimon Gilbody, Emily Peckham, Della Bailey, et al.
Pageof 3